CpG oligodeoxynucleotides directly induce CXCR3 chemokines in human B cells

Biochemical and Biophysical Research Communications

Volumn 320, Issue 4, 2004, Pages 1139-1147

  Kato, Atsushi ^a,b   Ogasawara, Takahisa ^a   Homma, Toshiki ^a   Batchelor, Jonathan ^a   Imai, Shosuke ^c   Wakiguchi, Hiroshi ^c   Saito, Hirohisa ^a,d   Matsumoto, Kenji ^a,d  

^a NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^b Nikken Chemicals Co Ltd   (Japan)

^c KOCHI MEDICAL SCHOOL   (Japan)

^d RIKEN YOKOHAMA INSTITUTE   (Japan)

Author keywords

B cells; CpG ODN; CXCR3 chemokines; I TAC; IP 10; Mig; TLR9

Indexed keywords

CHEMOKINE RECEPTOR CXCR3; I KAPPA B; INTERFERON RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MONOCLONAL ANTIBODY; OLIGODEOXYNUCLEOTIDE DERIVATIVE;

ARTICLE; B LYMPHOCYTE ACTIVATION; CELL STIMULATION; CONTROLLED STUDY; CPG ISLAND; CYTOKINE RELEASE; DRUG EFFECT; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; LEUKOCYTE ACTIVATION; LEUKOCYTE ADHERENCE INHIBITION; PRIORITY JOURNAL; TH1 CELL; UPREGULATION;

B-LYMPHOCYTES; CELL LINE; CHEMOKINES, CXC; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; OLIGODEOXYRIBONUCLEOTIDES; RECEPTORS, CHEMOKINE;

EID: 3142702136     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.06.059     Document Type: Article

References (49)

1. Zlotnik A., Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity. 12:2000;121-127
2. Sallusto F., Mackay C.R., Lanzavecchia A. The role of chemokine receptors in primary, effector, and memory immune responses. Annu. Rev. Immunol. 18:2000;593-620
3. Qin S., Rottman J.B., Myers P., Kassam N., Weinblatt M., Loetscher M., Koch A.E., Moser B., Mackay C.R. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J. Clin. Invest. 101:1998;746-754
4. Bonecchi R., Bianchi G., Bordignon P.P., D'Ambrosio D., Lang R., Borsatti A., Sozzani S., Allavena P., Gray P.A., Mantovani A., Sinigaglia F. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J. Exp. Med. 187:1998;129-134
5. Sallusto F., Lenig D., Mackay C.R., Lanzavecchia A. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J. Exp. Med. 187:1998;875-883
6. Finkelman F.D., Urban J.F. Jr. The other side of the coin: the protective role of the TH2 cytokines. J. Allergy Clin. Immunol. 107:2001;772-780
7. Mosmann T.R., Coffman R.L. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:1989;145-173
8. Liu A.H. Endotoxin exposure in allergy and asthma: reconciling a paradox. J. Allergy Clin. Immunol. 109:2002;379-392
9. Yamamoto S., Yamamoto T., Shimada S., Kuramoto E., Yano O., Kataoka T., Tokunaga T. DNA from bacteria, but not from vertebrates, induces interferons, activates natural killer cells and inhibits tumor growth. Microbiol. Immunol. 36:1992;983-997
10. Krieg A.M., Yi A.K., Matson S., Waldschmidt T.J., Bishop G.A., Teasdale R., Koretzky G.A., Klinman D.M. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature. 374:1995;546-549
11. Medzhitov R., Janeway C.A. Jr. Innate immunity: the virtues of a nonclonal system of recognition. Cell. 91:1997;295-298
12. Krieg A.M. The role of CpG motifs in innate immunity. Curr. Opin. Immunol. 12:2000;35-43
13. Rock F.L., Hardiman G., Timans J.C., Kastelein R.A., Bazan J.F. A family of human receptors structurally related to Drosophila Toll. Proc. Natl. Acad. Sci. USA. 95:1998;588-593
14. Takeda K., Kaisho T., Akira S. Toll-like receptors. Annu. Rev. Immunol. 21:2003;335-376
15. Hemmi H., Takeuchi O., Kawai T., Kaisho T., Sato S., Sanjo H., Matsumoto M., Hoshino K., Wagner H., Takeda K., Akira S. A Toll-like receptor recognizes bacterial DNA. Nature. 408:2000;740-745
16. Kadowaki N., Ho S., Antonenko S., Malefyt R.W., Kastelein R.A., Bazan F., Liu Y.J. Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J. Exp. Med. 194:2001;863-869
17. Hornung V., Rothenfusser S., Britsch S., Krug A., Jahrsdorfer B., Giese T., Endres S., Hartmann G. Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J. Immunol. 168:2002;4531-4537
18. Bernasconi N.L., Onai N., Lanzavecchia A. A role for Toll-like receptors in acquired immunity: up-regulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cells. Blood. 101:2003;4500-4504
19. Halperin S.A., Van Nest G., Smith B., Abtahi S., Whiley H., Eiden J.J. A phase I study of the safety and immunogenicity of recombinant hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide adjuvant. Vaccine. 21:2003;2461-2467
20. Krug A., Rothenfusser S., Hornung V., Jahrsdorfer B., Blackwell S., Ballas Z.K., Endres S., Krieg A.M., Hartmann G. Identification of CpG oligonucleotide sequences with high induction of IFN-alpha/beta in plasmacytoid dendritic cells. Eur. J. Immunol. 31:2001;2154-2163
21. Gursel M., Verthelyi D., Gursel I., Ishii K.J., Klinman D.M. Differential and competitive activation of human immune cells by distinct classes of CpG oligodeoxynucleotide. J. Leukoc. Biol. 71:2002;813-820
22. Hartmann G., Battiany J., Poeck H., Wagner M., Kerkmann M., Lubenow N., Rothenfusser S., Endres S. Rational design of new CpG oligonucleotides that combine B cell activation with high IFN-alpha induction in plasmacytoid dendritic cells. Eur. J. Immunol. 33:2003;1633-1641
23. Marshall J.D., Fearon K., Abbate C., Subramanian S., Yee P., Gregorio J., Coffman R.L., Van Nest G. Identification of a novel CpG DNA class and motif that optimally stimulate B cell and plasmacytoid dendritic cell functions. J. Leukoc. Biol. 73:2003;781-792
24. Kato A., Homma T., Batchelor J., Hashimoto N., Imai S., Wakiguchi H., Saito H., Matsumoto K. Interferon-alpha/beta receptor-mediated selective induction of a gene cluster by CpG oligodeoxynucleotide 2006. BMC Immunol. 4:2003;8
25. Kato A., Ogasawara T., Homma T., Saito H., Matsumoto K. Lipopolysaccharide-binding protein critically regulates lipopolysaccharide- induced IFN-beta signaling pathway in human monocytes. J. Immunol. 172:2004;6185-6194
26. Tulic M.K., Fiset P.O., Christodoulopoulos P., Vaillancourt P., Desrosiers M., Lavigne F., Eiden J., Hamid Q. Amb a 1-immunostimulatory oligodeoxynucleotide conjugate immunotherapy decreases the nasal inflammatory response. J. Allergy Clin. Immunol. 113:2004;235-241
27. Verthelyi D., Ishii K.J., Gursel M., Takeshita F., Klinman D.M. Human peripheral blood cells differentially recognize and respond to two distinct CPG motifs. J. Immunol. 166:2001;2372-2377
28. Sauty A., Dziejman M., Taha R.A., Iarossi A.S., Neote K., Garcia-Zepeda E.A., Hamid Q., Luster A.D. The T cell-specific CXC chemokines IP-10, Mig, and I-TAC are expressed by activated human bronchial epithelial cells. J. Immunol. 162:1999;3549-3558
29. Gasperini S., Marchi M., Calzetti F., Laudanna C., Vicentini L., Olsen H., Murphy M., Liao F., Farber J., Cassatella M.A. Gene expression and production of the monokine induced by IFN-gamma (MIG), IFN-inducible T cell alpha chemoattractant (I-TAC), and IFN-gamma-inducible protein-10 (IP-10) chemokines by human neutrophils. J. Immunol. 162:1999;4928-4937
30. Padovan E., Spagnoli G.C., Ferrantini M., Heberer M. IFN-alpha2a induces IP-10/CXCL10 and MIG/CXCL9 production in monocyte-derived dendritic cells and enhances their capacity to attract and stimulate CD8+ effector T cells. J. Leukoc. Biol. 71:2002;669-676
31. Takeshita S., Takeshita F., Haddad D.E., Ishii K.J., Klinman D.M. CpG oligodeoxynucleotides induce murine macrophages to up-regulate chemokine mRNA expression. Cell Immunol. 206:2000;101-106
32. Krug A., Towarowski A., Britsch S., Rothenfusser S., Hornung V., Bals R., Giese T., Engelmann H., Endres S., Krieg A.M., Hartmann G. Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12. Eur. J. Immunol. 31:2001;3026-3037
33. Blackwell S.E., Krieg A.M. CpG-A-induced monocyte IFN-gamma-inducible protein-10 production is regulated by plasmacytoid dendritic cell-derived IFN-alpha. J. Immunol. 170:2003;4061-4068
34. Tibbles L.A., Spurrell J.C., Bowen G.P., Liu Q., Lam M., Zaiss A.K., Robbins S.M., Hollenberg M.D., Wickham T.J., Muruve D.A. Activation of p38 and ERK signaling during adenovirus vector cell entry lead to expression of the C-X-C chemokine IP-10. J. Virol. 76:2002;1559-1568
35. Kutsch O., Oh J., Nath A., Benveniste E.N. Induction of the chemokines interleukin-8 and IP-10 by human immunodeficiency virus type 1 tat in astrocytes. J. Virol. 74:2000;9214-9221
36. Asensio V.C., Maier J., Milner R., Boztug K., Kincaid C., Moulard M., Phillipson C., Lindsley K., Krucker T., Fox H.S., Campbell I.L. Interferon-independent, human immunodeficiency virus type 1 gp120-mediated induction of CXCL10/IP-10 gene expression by astrocytes in vivo and in vitro. J. Virol. 75:2001;7067-7077
37. Ahmad-Nejad P., Hacker H., Rutz M., Bauer S., Vabulas R.M., Wagner H. Bacterial CpG-DNA and lipopolysaccharides activate Toll-like receptors at distinct cellular compartments. Eur. J. Immunol. 32:2002;1958-1968
38. Yi A.K., Yoon J.G., Hong S.C., Redford T.W., Krieg A.M. Lipopolysaccharide and CpG DNA synergize for tumor necrosis factor-alpha production through activation of NF-kappaB. Int. Immunol. 13:2001;1391-1404
39. Wagner M., Poeck H., Jahrsdoerfer B., Rothenfusser S., Prell D., Bohle B., Tuma E., Giese T., Ellwart J.W., Endres S., Hartmann G. IL-12p70-dependent Th1 induction by human B cells requires combined activation with CD40 ligand and CpG DNA. J. Immunol. 172:2004;954-963
40. Siegal F.P., Kadowaki N., Shodell M., Fitzgerald-Bocarsly P.A., Shah K., Ho S., Antonenko S., Liu Y.J. The nature of the principal type 1 interferon-producing cells in human blood. Science. 284:1999;1835-1837
41. Yi A.K., Klinman D.M., Martin T.L., Matson S., Krieg A.M. Rapid immune activation by CpG motifs in bacterial DNA. Systemic induction of IL-6 transcription through an antioxidant-sensitive pathway. J. Immunol. 157:1996;5394-5402
42. Jahrsdorfer B., Hartmann G., Racila E., Jackson W., Muhlenhoff L., Meinhardt G., Endres S., Link B.K., Krieg A.M., Weiner G.J. CpG DNA increases primary malignant B cell expression of costimulatory molecules and target antigens. J. Leukoc. Biol. 69:2001;81-88
43. Park Y., Chang Y.S., Lee S.W., Cho S.Y., Kim Y.K., Min K.U., Kim Y.Y., Cho S.H., Sung Y.C. The enhanced effect of a hexameric deoxyriboguanosine run conjugation to CpG oligodeoxynucleotides on protection against allergic asthma. J. Allergy Clin. Immunol. 108:2001;570-576
44. Vasilakos J.P., Smith R.M., Gibson S.J., Lindh J.M., Pederson L.K., Reiter M.J., Smith M.H., Tomai M.A. Adjuvant activities of immune response modifier R-848: comparison with CpG ODN. Cell Immunol. 204:2000;64-74
45. Liu N., Ohnishi N., Ni L., Akira S., Bacon K.B. CpG directly induces T-bet expression and inhibits IgG1 and IgE switching in B cells. Nat. Immunol. 4:2003;687-693
46. Peng S.L., Li J., Lin L., Gerth A. The role of T-bet in B cells. Nat. Immunol. 4:2003;1041. author reply 1041
47. Loetscher P., Pellegrino A., Gong J.H., Mattioli I., Loetscher M., Bardi G., Baggiolini M., Clark-Lewis I. The ligands of CXC chemokine receptor 3, I-TAC, Mig, and IP10, are natural antagonists for CCR3. J. Biol. Chem. 276:2001;2986-2991
48. Fulkerson P.C., Zimmermann N., Brandt E.B., Muntel E.E., Doepker M.P., Kavanaugh J.L., Mishra A., Witte D.P., Zhang H., Farber J.M., Yang M., Foster P.S., Rothenberg M.E. Negative regulation of eosinophil recruitment to the lung by the chemokine monokine induced by IFN-gamma (Mig, CXCL9). Proc. Natl. Acad. Sci. USA. 101:2004;1987-1992
49. Zdilar D., Franco-Bronson K., Buchler N., Locala J.A., Younossi Z.M. Hepatitis C, interferon alfa, and depression. Hepatology. 31:2000;1207-1211